Loading
Life sciences · Interventional Study
ClinicalTrials.gov · September 29, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Interventional Study.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Registry record from ClinicalTrials.gov (NCT06397339). This is a study registration, not published results. Lead sponsor: Washington State University. Recruitment status: COMPLETED. Phase: NA. Study type: INTERVENTIONAL. Enrollment: 7 participants (ACTUAL). Conditions: Alzheimer Disease. Interventions: OTHER: INTACT Program. Primary outcome measures: Clinic Level - new diagnoses of ADRD and MCI (Aim 2) , Baseline and 12-month follow-up; PCP level - care confidence (Aim 1) , Baseline and a 12-month follow-up; Patient level - quality of care 1 (Aim 3) , Baseline and a 12-month follow-up; Patient level - quality of care 2 (Aim 3) , Baseline and a 12-month follow-up; Patient level - quality of care 3 (Aim 3) , Baseline and a 12-month follow-up; Patient level - quality of care 4 (Aim 3) , Baseline and a 12-month follow-up; Patient level - quality of care 5 (Aim 3) , Baseline and a 12-month follow-up; Patient level - quality of care 5 (Aim 3) , Baseline and a 12-month follow-up. Brief summary: INTACT will utilize a group-randomized trial, to test the effectiveness of a culturally informed provider training and "dementia friendly clinic" intervention for detection and appropriate management of AI/AN patients with ADRD and MCI in 28 urban and rural clinics serving AI/ANs.